{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:51:22Z","timestamp":1767772282439,"version":"build-2065373602"},"reference-count":30,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>SARS-CoV-2 virulence is known to increase with lowering of environmental temperature and solar ultraviolet radiation; therefore, we have focused our real-world nationwide study concerning with COVID-19 trend and dynamics on the coldest seasons of the year in Italy, the Western country hardest hit at the onset of the pandemic, comparing the autumn\u2013winter of 2020 (before mass vaccination but when the emergency machinery was fully operative in terms of tracing and swabs) with the autumn\u2013winter of 2021 (after mass vaccination), and analyzing the mortality burden by age groups and life stages in the years 2019 (pre-COVID-19), 2020 (before mass vaccination), and 2021 (after mass vaccination). Methods: During the state of national health emergency, the Civil Defense Department released the aggregate data coming from the Higher Institute of Health, the Ministry of Health, the Italian Regions, and the Independent Provinces, to inform the population about the pandemic situation, daily. Among these data, there were the number of contagions, performed swabs, hospitalizations in Intensive Care Units (ICU), non-ICU patients, and deaths. By means of a team effort, we have collected and elaborated all these data, comparing the COVID-19 pandemic in Italy during the autumn\u2013winter of 2020 with the autumn\u2013winter of 2021. Moreover, we have extracted from the database of the National Institute of Statistics the total number of annual deaths in Italy during the years 2019, 2020, and 2021, comparing them to each other in order to evaluate the mortality burden attributable to COVID-19. Results: From the autumn\u2013winter of 2020 to the autumn\u2013winter of 2021, the contagions increased by \u2248285%, against a \u2248290% increase in the performed swabs; therefore, the mean positivity rate passed from 8.74% before mass vaccination to 8.59% after mass vaccination. The unprecedent vaccination campaign allowed a \u2248251% abatement in COVID-19 deaths, and a reduction of \u2248224% and \u2248228% in daily ICU and non-ICU hospitalizations due to COVID-19, respectively. Regarding COVID-19 deaths, in 2020, there was a mortality excess of \u224814.3% quantifiable in 105,900 more deaths compared to 2019, the pre-COVID-19 year; 103,183 out of 105,900 deaths occurred in older adults (\u226560 years), which is equivalent to \u224897.4%, while in adults over 50, the segment of population just below older adults, in 2020, there were 2807 more deaths than in 2019. Surprisingly, from the analysis of our data, it is emerged that in people under the age of 40 in the years 2019, 2020, and 2021, there were 7103, 6808, and 7165 deaths, respectively. This means that in subjects under 40 during 2020, there were 295 fewer deaths than in 2019, while during 2021, there were 357 more deaths than in 2020, equivalent to \u22485.2% more. Conclusions: COVID-19 is a potential life-threatening disease mainly in older adults, as they are the most vulnerable due to inherent immunosenescence and inflammaging. Extensive vaccination in this segment of population with up-to-date vaccines is the means to reduce deaths, hospitalizations, and ICU pressure in the public interest. In the event of future threats, a new mass vaccination campaign should not be implemented without taking into account the individual age; it should primarily be aimed at people over 60 and at patients of any age with immune deficits, and secondly at people over 50. COVID-19 vaccination shows a favorable benefit\u2013risk ratio in older adults, while the balance steps down under the age of 40; this younger segment of the population should be therefore exempt from any mandatory vaccination.<\/jats:p>","DOI":"10.3390\/microorganisms12030435","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T04:23:10Z","timestamp":1708489390000},"page":"435","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Real-World Nationwide Study on COVID-19 Trend in Italy during the Autumn\u2013Winter Season of 2020 (before Mass Vaccination) and 2021 (after Mass Vaccination) Integrated with a Retrospective Analysis of the Mortality Burden per Year"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6949-2216","authenticated-orcid":false,"given":"Luca","family":"Roncati","sequence":"first","affiliation":[{"name":"Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplantation, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41121 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Galeazzi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplantation, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41121 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Bartolacelli","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplantation, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41121 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Caramaschi","sequence":"additional","affiliation":[{"name":"Department of Maternal, Infant and Adult Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41121 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1002\/jmv.26924","article-title":"Nucleoside-modified messenger RNA COVID-19 vaccine platform","volume":"93","author":"Roncati","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_2","unstructured":"World Health Organization (2024, January 01). WHO Coronavirus (COVID-19) Dashboard. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_3","unstructured":"Italian Government (2023, September 24). Anti COVID-19 Vaccines Report, Available online: https:\/\/www.governo.it\/it\/cscovid19\/report-vaccini\/."},{"key":"ref_4","unstructured":"Italian Institute of Statistics (2023, April 07). Demographic Indicators\u2014Year 2022. Available online: https:\/\/www.istat.it\/it\/files\/\/2023\/04\/indicatori-anno-2022.pdf."},{"key":"ref_5","unstructured":"Italian Institute of Statistics (2022, April 08). Demographic Indicators\u2014Year 2021. Available online: https:\/\/www.istat.it\/it\/files\/\/2022\/04\/Report-Indicatori-Demografici_2021.pdf."},{"key":"ref_6","unstructured":"Italian Institute of Statistics (2021, May 03). Demographic Indicators\u2014Year 2020. Available online: https:\/\/www.istat.it\/it\/files\/\/2021\/05\/REPORT_INDICATORI-DEMOGRAFICI-2020.pdf."},{"key":"ref_7","unstructured":"Italian Institute of Statistics (2020, February 11). Demographic Indicators\u2014Year 2019. Available online: https:\/\/www.istat.it\/it\/files\/2020\/02\/Indicatori-demografici_2019.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1038\/s41467-021-23866-7","article-title":"Role of meteorological factors in the transmission of SARS-CoV-2 in the United States","volume":"12","author":"Ma","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"115796","DOI":"10.1016\/j.envres.2023.115796","article-title":"The influence of meteorological factors on COVID-19 spread in Italy during the first and second wave","volume":"228","author":"Balboni","year":"2023","journal-title":"Environ. Res."},{"key":"ref_10","unstructured":"Italian Minister of Health (2023, August 28). COVID-19 Dashboard. Available online: https:\/\/opendatamds.maps.arcgis.com\/apps\/dashboards\/0f1c9a02467b45a7b4ca12d8ba296596."},{"key":"ref_11","unstructured":"Italian Institute of Statistics (2023, August 28). Deaths. Available online: http:\/\/dati.istat.it\/Index.aspx?lang=en&SubSessionId=950b3a5b-2916-4ba0-975a-6d3cfc712ac5."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S2666-7568(21)00115-X","article-title":"A call for standardised age-disaggregated health data","volume":"2","author":"Diaz","year":"2021","journal-title":"Lancet Healthy Longev."},{"key":"ref_13","first-page":"17","article-title":"The COVID-19 pandemic spread on hospital admissions in the Bolzano Province (Italy): A descriptive study (February 2020\u2013March 2022)","volume":"3","author":"Bonetti","year":"2022","journal-title":"Boll. Epidemiol. Naz."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/irv.12682","article-title":"Effects of temperature, humidity, and diurnal temperature range on influenza incidence in a temperate region","volume":"14","author":"Park","year":"2020","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_15","unstructured":"Italian Drug Agency (2022, March 26). COVID-19 Vaccine Surveillance\u201411th Report, Available online: https:\/\/www.aifa.gov.it\/documents\/20142\/1315190\/Rapporto_sorveglianza_vaccini_COVID-19_11.pdf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S2666-7568(20)30011-8","article-title":"Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults","volume":"1","author":"Cox","year":"2020","journal-title":"Lancet Healthy Longev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s43587-020-00021-3","article-title":"How inflammaging diminishes adaptive immunity","volume":"1","author":"Kasler","year":"2021","journal-title":"Nat. Aging"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Br\u00e1bek, J., Jakubek, M., Vellieux, F., Novotn\u00fd, J., Kol\u00e1\u0159, M., Lacina, L., Szabo, P., Strnadov\u00e1, K., R\u00f6sel, D., and Dvo\u0159\u00e1nkov\u00e1, B. (2020). Interleukin-6: Molecule in the intersection of cancer, ageing and COVID-19. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21217937"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"108487","DOI":"10.1016\/j.clim.2020.108487","article-title":"Type 3 hypersensitivity in COVID-19 vasculitis","volume":"217","author":"Roncati","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2141","article-title":"Interleukin-6 in COVID-19: A systematic review and meta-analysis","volume":"30","author":"Coomes","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jaci.2020.07.001","article-title":"The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection","volume":"146","author":"Copaescu","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Roncati, L., Manenti, A., and Corsi, L. (2022). A three-case series of thrombotic deaths in patients over 50 with comorbidities temporally after modRNA COVID-19 vaccination. Pathogens, 11.","DOI":"10.3390\/pathogens11040435"},{"key":"ref_26","unstructured":"European Medicines Agency (2021, April 13). VAXZEVRIA\/COVID-19 Vaccine AstraZeneca: Link between the Vaccine and the Occurrence of Thrombosis in Combination with Thrombocytopenia. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/dhpc\/direct-healthcare-professional-communication-dhpc-vaxzevria-previously-covid-19-vaccine-astrazeneca_en-0.pdf."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Roncati, L., Bartolacelli, G., Galeazzi, C., and Caramaschi, S. (2023). Trends in the COVID-19 pandemic in Italy during the summers of 2020 (before mass vaccination), 2021 (after primary mass vaccination) and 2022 (after booster mass vaccination): A real-world nationwide study based on a population of 58.85 million people. Pathogens, 12.","DOI":"10.20944\/preprints202310.1484.v1"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11543","DOI":"10.1038\/s41598-023-38327-y","article-title":"Estimating generation time of SARS-CoV-2 variants in Italy from the daily incidence rate","volume":"13","author":"Lippiello","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Xia, Q., Yang, Y., Wang, F., Huang, Z., Qiu, W., and Mao, A. Case fatality rates of COVID-19 during epidemic periods of variants of concern: A meta-analysis by continents. Int. J. Infect. Dis., 2024. in press.","DOI":"10.1016\/j.ijid.2024.01.017"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100350","DOI":"10.1016\/j.puhip.2022.100350","article-title":"Differences in case-fatality-rate of emerging SARS-CoV-2 variants","volume":"5","author":"Liu","year":"2023","journal-title":"Public Health Pract."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/3\/435\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:02:11Z","timestamp":1760104931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/3\/435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["microorganisms12030435"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms12030435","relation":{},"ISSN":["2076-2607"],"issn-type":[{"type":"electronic","value":"2076-2607"}],"subject":[],"published":{"date-parts":[[2024,2,21]]}}}